SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000874015-15-000057
Filing Date
2015-05-05
Accepted
2015-05-05 16:53:41
Documents
12
Period of Report
2015-03-31

Document Format Files

Seq Description Document Type Size
1 ISIS PHARMACEUTICALS INC 10-Q 3-31-2015 form10q.htm 10-Q 980484
2 EXHIBIT 10.1 ex10_1.htm EX-10.1 520431
3 EXHIBIT 10.2 ex10_2.htm EX-10.2 33218
4 EXHIBIT 31.1 ex31_1.htm EX-31.1 7685
5 EXHIBIT 31.2 ex31_2.htm EX-31.2 7354
6 EXHIBIT 32.1 ex32_1.htm EX-32.1 5606
  Complete submission text file 0000874015-15-000057.txt   8459496

Data Files

Seq Description Document Type Size
7 XBRL INSTANCE DOCUMENT isis-20150331.xml EX-101.INS 1234866
8 XBRL TAXONOMY EXTENSION SCHEMA isis-20150331.xsd EX-101.SCH 58867
9 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE isis-20150331_cal.xml EX-101.CAL 56084
10 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE isis-20150331_def.xml EX-101.DEF 350150
11 XBRL TAXONOMY EXTENSION LABEL LINKBASE isis-20150331_lab.xml EX-101.LAB 702192
12 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE isis-20150331_pre.xml EX-101.PRE 427994
Mailing Address 2855 GAZELLE COURT CARLSBAD CA 92010
Business Address 2855 GAZELLE COURT CARLSBAD CA 92010 7609319200
ISIS PHARMACEUTICALS INC (Filer) CIK: 0000874015 (see all company filings)

IRS No.: 330336973 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-19125 | Film No.: 15833764
SIC: 2834 Pharmaceutical Preparations